Roxana Mehran

Roxana Mehran

Professor of Medicine, Cardiology and Professor of Population Health Science and Policy

MD

Mount Sinai Hospital, New York, NY, US

  • LinkedIn
  • Radcliffe
  • OrcidID

Biography

Roxana Mehran is Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past 5 years, she has led the development of a globally respected data and clinical coordination centre to support large, multicentre, multinational clinical trials designed to help improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper understanding of anticoagulation and antiplatelet regimens post angioplasty and transcatheter valve replacement; and collection and interpretation of sex-specific data in cardiovascular clinical trials.

Roxana serves on editorial board of multiple peer reviewed journals, including Journal of the American College of Cardiology, Circulation and Circulation Research. She currently serves on the board of trustees of Society of Cardiac Angiography and Intervention, as a member of the Program Committee for the American Heart Association Scientific Sessions, as a member of the board of directors for Harboring Hearts, and as Program Chair for Society of Cardiac Angiography and Interventions' Women in Innovations Initiative, and is the Chief Scientific Officer of the Clinical Trials Center at the Cardiovascular Research Foundation.

Roxana is on the editorial board of Interventional Cardiology: Reviews, Research, Resources.

Read more

Media

Antoinette Neylon, Roxana Mehran, Martin Swaans, et al

Watch time: 45m 15s (8 videos)

Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, et al

Watch time: 3h

Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, et al

Watch time: 4h

Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, et al

Watch time: 4h
Uniform Pathway of Care for OHCA: Key Messages from the BCIS Statement

Nick Curzen, Tom Keeble, Peter O’Kane, et al

Watch time: 35m 11s

Nicolas M Van Mieghem, Holger Thiele, Azeem Latib, et al

Watch time: 14h 38m 12s (23 videos)

Roxana Mehran, Pascal Vranckx, Marco Valgimigli, et al

Watch time: 1h 27m 41s (4 videos)

Nicolas M Van Mieghem, Roxana Mehran, Holger Thiele, et al

Watch time: 4h

David Hildick-Smith, Ajay J Kirtane, Nicolas M Van Mieghem, et al

Watch time: 4h

Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, et al

Watch time: 4h

Robert F Storey, Roxana Mehran, Dominick J Angiolillo, et al

Watch time: 1h 45m 35s (7 videos)
Transcatheter Interventions Online 2022 - On Demand

Joost Daemen, Roxana Mehran, David Hildick-Smith, et al

USC 21 Discussion: Women In Cardiology

Roxana Mehran, Shrilla Banerjee, Burt Cohen, et al

Watch time: 32m 29s

Nicolas M Van Mieghem, Holger Thiele, Roxana Mehran, et al

Nicolas M Van Mieghem, Holger Thiele, Roxana Mehran, et al

Nicolas M Van Mieghem, Roxana Mehran, Kendra J Grubb, et al

Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, et al

Watch time: 14h 48m 39s (16 videos)

Dominick J Angiolillo, Robert F Storey, Roxana Mehran, et al

Watch time: 1h 28m 48s (5 videos)
TCT Connect 2020: The XIENCE 90/28 Trials

Roxana Mehran,

Watch time: 8m 43s

Kurt Huber, Davide Capodanno, Roxana Mehran, et al

Watch time: 1h 1m 15s (5 videos)
Mending the broken house of cardiology with Roxana Mehran

Ankur Kalra, Roxana Mehran,

Listen time: 40m 55s
CRT 2020: Should we drop aspirin monotherapy?

Roxana Mehran,

Watch time: 6m 21s
AHA 2019: Clinical Data Update on Antithrombotics

Marc P Bonaca, Roxana Mehran,

Watch time: 17m 29s
AHA 2019: Clinical Data Update on TWILIGHT and TWILIGHT-ACS

Marc P Bonaca, Roxana Mehran,

Watch time: 5m 5s
AHA 2019: Clinical Data Update on GALILEO

Roxana Mehran, Marc P Bonaca,

Watch time: 7m 49s
AHA 2019: Clinical Data Update on ISCHEMIA

Marc P Bonaca, Roxana Mehran,

Watch time: 7m 49s
AHA 2019 Discussion: Women in Cardiology

Harriette Van Spall, Roxana Mehran,

Watch time: 10m 32s
ESC 2018: The DIAB8 Study - Prof Roxana Mehran

Roxana Mehran,

Watch time: 4m 3s

Articles by Roxana Mehran, Professor of Medicine, Cardiology and Professor of Population Health Science and Policy

Artificial Intelligence – Advisory or Adversary?

Johny Nicolas, Nicholas L Pitaro, Birgit Vogel, et al

Published:

Citation: Interventional Cardiology 2023;18:e17.

DOI:

https://doi.org/10.15420/icr.2022.22
Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients with Ischaemic Heart Disease

Antonia Sambola, Bruno García Del Blanco, Vijay Kunadian, et al

Published:

Citation: European Cardiology Review 2023;18:e06.

DOI:

https://doi.org/10.15420/ecr.2022.24
British Cardiovascular Interventional Society Consensus: a Huge Step Towards Standardised Care for Out-of-hospital Cardiac Arrest in the UK

Marko Noc, Roxana Mehran,

Published:

Citation: Interventional Cardiology 2022;17:e17.

DOI:

https://doi.org/10.15420/icr.2022.25
The Final Word: Current Strategies for the Lifetime Management of Patients with Aortic Valve Stenosis

Anne H Tavenier, Johny Nicolas, Roxana Mehran, et al

Published:

Citation: US Cardiology Review 2022;16:e13.

DOI:

https://doi.org/10.15420/usc.2022.07
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention

Johny Nicolas, Usman Baber, Roxana Mehran, et al

Published:

Citation: US Cardiology Review 2020;14:e04.

DOI:

https://doi.org/10.15420/usc.2019.02
Non-vitamin K Antagonist Oral Anticoagulant After Acute Coronary Syndrome: Is There a Role?

Paul Guedeney, Birgit Vogel, Roxana Mehran, et al

Citation: Interventional Cardiology Review 2018;13(2):93–8.

DOI:

https://doi.org/10.15420/icr.2018:5:2
Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?

Michela Faggioni, Michael C Gibson, Roxana Mehran, et al

Citation: US Cardiology Review 2017; 11(1):37–8

DOI:

https://doi.org/10.15420/usc.2017:6:1.GE
Preventing Contrast-induced Renal Failure: A Guide

Michela Faggioni, Roxana Mehran,

Citation: Interventional Cardiology Review 2016;11(2):98–104

DOI:

https://doi.org/10.15420/icr.2016:10:2
Cre8™ Unique Technology in Challenging Daily Practice

David Antoniucci, Roxana Mehran, Giuseppe DeLuca, et al

Citation: Interventional Cardiology Review 2014;9(3):180–3

DOI:

https://doi.org/10.15420/icr.2014.9.3.180
Contrast-induced Nephropathy in a High-risk Patient Population

Adriano Caixeta, Eugenia Nikolsky, Roxana Mehran, et al

Citation: Interventional Cardiology 2008;3(1):10-5

DOI:

https://doi.org/10.15420/icr.2008.3.1.10
The Role of New Antiplatelet Agents in Percutaneous Coronary Intervention

Benjamin Galper, Roxana Mehran,

Citation: Interventional Cardiology 2009;4(1):81-4

DOI:

https://doi.org/10.15420/icr.2009.4.1.81